Moreover, reports indicate that TRAIL can induce cell death in CML cells that are refractory to STI571, and vice versa STI571 can overcome TRAIL resistance in K562 cells [25-27]. This evidence concerns the gene TNFSF10 and chronic myelogenous leukemia, BCR-ABL1 positive.